Shanghai Pioneer Holding Ltd

SEHK:1345 株式レポート

時価総額:HK$2.7b

Shanghai Pioneer Holding マネジメント

マネジメント 基準チェック /44

現在、CEO に関する十分な情報がありません。

主要情報

Steven Yang

最高経営責任者

CN¥655.0k

報酬総額

CEO給与比率78.8%
CEO在任期間1.7yrs
CEOの所有権n/a
経営陣の平均在職期間4.5yrs
取締役会の平均在任期間3yrs

経営陣の近況

Recent updates

Shanghai Pioneer Holding Ltd (HKG:1345) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Dec 10
Shanghai Pioneer Holding Ltd (HKG:1345) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Shareholders Should Be Pleased With Shanghai Pioneer Holding Ltd's (HKG:1345) Price

Jul 15
Shareholders Should Be Pleased With Shanghai Pioneer Holding Ltd's (HKG:1345) Price

Shanghai Pioneer Holding's (HKG:1345) Dividend Will Be CN¥0.024

Apr 24
Shanghai Pioneer Holding's (HKG:1345) Dividend Will Be CN¥0.024

Shanghai Pioneer Holding (HKG:1345) Will Pay A Dividend Of CN¥0.024

Apr 03
Shanghai Pioneer Holding (HKG:1345) Will Pay A Dividend Of CN¥0.024

Shanghai Pioneer Holding's (HKG:1345) Shareholders Have More To Worry About Than Only Soft Earnings

Apr 01
Shanghai Pioneer Holding's (HKG:1345) Shareholders Have More To Worry About Than Only Soft Earnings

Shanghai Pioneer Holding Ltd (HKG:1345) Could Be Riskier Than It Looks

Mar 22
Shanghai Pioneer Holding Ltd (HKG:1345) Could Be Riskier Than It Looks

Shanghai Pioneer Holding (HKG:1345) Is Finding It Tricky To Allocate Its Capital

Feb 26
Shanghai Pioneer Holding (HKG:1345) Is Finding It Tricky To Allocate Its Capital

Does Shanghai Pioneer Holding (HKG:1345) Have A Healthy Balance Sheet?

Oct 21
Does Shanghai Pioneer Holding (HKG:1345) Have A Healthy Balance Sheet?

Shanghai Pioneer Holding (HKG:1345) Has Announced That It Will Be Increasing Its Dividend To CN¥0.024

Sep 18
Shanghai Pioneer Holding (HKG:1345) Has Announced That It Will Be Increasing Its Dividend To CN¥0.024

Shanghai Pioneer Holding (HKG:1345) Is Increasing Its Dividend To CN¥0.024

Sep 01
Shanghai Pioneer Holding (HKG:1345) Is Increasing Its Dividend To CN¥0.024

Here's Why We Think Shanghai Pioneer Holding (HKG:1345) Is Well Worth Watching

Aug 09
Here's Why We Think Shanghai Pioneer Holding (HKG:1345) Is Well Worth Watching

Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Apr 14
Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Mar 31
Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Shanghai Pioneer Holding (HKG:1345) Seems To Use Debt Rather Sparingly

Dec 15
Shanghai Pioneer Holding (HKG:1345) Seems To Use Debt Rather Sparingly

China Pioneer Pharma Holdings' (HKG:1345) Dividend Will Be Reduced To CN¥0.018

Sep 21
China Pioneer Pharma Holdings' (HKG:1345) Dividend Will Be Reduced To CN¥0.018

China Pioneer Pharma Holdings' (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Sep 02
China Pioneer Pharma Holdings' (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

China Pioneer Pharma Holdings (HKG:1345) Has More To Do To Multiply In Value Going Forward

Jun 22
China Pioneer Pharma Holdings (HKG:1345) Has More To Do To Multiply In Value Going Forward

China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.064

Apr 14
China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.064

China Pioneer Pharma Holdings (HKG:1345) Will Be Hoping To Turn Its Returns On Capital Around

Jan 16
China Pioneer Pharma Holdings (HKG:1345) Will Be Hoping To Turn Its Returns On Capital Around

These 4 Measures Indicate That China Pioneer Pharma Holdings (HKG:1345) Is Using Debt Safely

Oct 11
These 4 Measures Indicate That China Pioneer Pharma Holdings (HKG:1345) Is Using Debt Safely

China Pioneer Pharma Holdings (HKG:1345) Is Paying Out Less In Dividends Than Last Year

Sep 15
China Pioneer Pharma Holdings (HKG:1345) Is Paying Out Less In Dividends Than Last Year

China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.056

Sep 01
China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.056

China Pioneer Pharma Holdings (HKG:1345) Will Be Looking To Turn Around Its Returns

Aug 26
China Pioneer Pharma Holdings (HKG:1345) Will Be Looking To Turn Around Its Returns

Returns On Capital At China Pioneer Pharma Holdings (HKG:1345) Paint A Concerning Picture

May 22
Returns On Capital At China Pioneer Pharma Holdings (HKG:1345) Paint A Concerning Picture

We Think China Pioneer Pharma Holdings (HKG:1345) Can Stay On Top Of Its Debt

Apr 25
We Think China Pioneer Pharma Holdings (HKG:1345) Can Stay On Top Of Its Debt

Can Mixed Financials Have A Negative Impact on China Pioneer Pharma Holdings Limited's 's (HKG:1345) Current Price Momentum?

Mar 14
Can Mixed Financials Have A Negative Impact on China Pioneer Pharma Holdings Limited's 's (HKG:1345) Current Price Momentum?

How Has China Pioneer Pharma Holdings (HKG:1345) Allocated Its Capital?

Feb 21
How Has China Pioneer Pharma Holdings (HKG:1345) Allocated Its Capital?

Should You Use China Pioneer Pharma Holdings' (HKG:1345) Statutory Earnings To Analyse It?

Feb 03
Should You Use China Pioneer Pharma Holdings' (HKG:1345) Statutory Earnings To Analyse It?

Is China Pioneer Pharma Holdings Limited (HKG:1345) At Risk Of Cutting Its Dividend?

Jan 16
Is China Pioneer Pharma Holdings Limited (HKG:1345) At Risk Of Cutting Its Dividend?

China Pioneer Pharma Holdings (HKG:1345) Has A Rock Solid Balance Sheet

Dec 29
China Pioneer Pharma Holdings (HKG:1345) Has A Rock Solid Balance Sheet

Is China Pioneer Pharma Holdings Limited's (HKG:1345) Stock Price Struggling As A Result Of Its Mixed Financials?

Dec 14
Is China Pioneer Pharma Holdings Limited's (HKG:1345) Stock Price Struggling As A Result Of Its Mixed Financials?

China Pioneer Pharma Holdings (HKG:1345) Has Gifted Shareholders With A Fantastic 124% Total Return On Their Investment

Nov 29
China Pioneer Pharma Holdings (HKG:1345) Has Gifted Shareholders With A Fantastic 124% Total Return On Their Investment

CEO報酬分析

Shanghai Pioneer Holding の収益と比較して、Steven Yang の報酬はどのように変化したか?
日付総報酬給与会社業績
Jun 30 2024n/an/a

CN¥164m

Mar 31 2024n/an/a

CN¥155m

Dec 31 2023CN¥655kCN¥516k

CN¥146m

Sep 30 2023n/an/a

CN¥168m

Jun 30 2023n/an/a

CN¥190m

Mar 31 2023n/an/a

CN¥213m

Dec 31 2022CN¥752kCN¥624k

CN¥235m

報酬と市場: Stevenの 総報酬 ($USD 89.77K ) は、 Hong Kong市場 ($USD 393.64K ) の同様の規模の企業の平均を下回っています。

報酬と収益: Stevenの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Steven Yang (36 yo)

1.7yrs

在職期間

CN¥655,000

報酬

Mr. Yuewen Yang, also known as Steven, serves as Chief Executive Officer since April 2023 and serves as its Executive Director since September 16, 2022 and served as Chief Operating Officer at Shanghai Pio...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Zhang Xinzhou Li
Executive Chairman11.8yrsCN¥2.05m0.95%
HK$ 25.6m
Yuewen Yang
CEO & Executive Director1.7yrsCN¥655.00kデータなし
Quan Zhang
General Manager of Dental Business Division & Executive Director3.3yrsCN¥717.00kデータなし
Yi Xue
Chief Financial Officer8yrsデータなしデータなし
Yong Zheng
General Manager of Investment Unitno dataデータなしデータなし
Jie Wang
Director of Personnelno dataデータなしデータなし
Ka Man Ng
Company Secretary5.8yrsデータなしデータなし

4.5yrs

平均在職期間

49yo

平均年齢

経験豊富な経営陣: 1345の経営陣は 経験豊富 であると考えられます ( 4.5年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Zhang Xinzhou Li
Executive Chairman11.8yrsCN¥2.05m0.95%
HK$ 25.6m
Yuewen Yang
CEO & Executive Director2.3yrsCN¥655.00kデータなし
Quan Zhang
General Manager of Dental Business Division & Executive Director1.2yrsCN¥717.00kデータなし
Chanshu Lai
Independent Non-Executive Director3yrsCN¥270.00kデータなし
Hong Zhang
Independent Non-Executive Director5.9yrsデータなしデータなし
Mingfei Hu
Non-Executive Director4yrsCN¥184.00kデータなし
Changhai Zhang
Independent Non-Executive Directorless than a yearデータなしデータなし

3.0yrs

平均在職期間

60yo

平均年齢

経験豊富なボード: 1345の 取締役会経験豊富 であると考えられます ( 3年の平均在任期間)。


企業分析と財務データの現状

データ最終更新日(UTC時間)
企業分析2024/12/22 06:17
終値2024/12/20 00:00
収益2024/06/30
年間収益2023/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を例とし、非米国証券については同等の規制書式と情報源を使用

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら

分析モデルとスノーフレーク

このレポートの作成に使用した分析モデルの詳細は、Githubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeでのチュートリアルもご用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Shanghai Pioneer Holding Ltd 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。6

アナリスト機関
Bo LiBOCOM International Securities Limited
Kenneth LiCinda International Research Limited
Sze Chuen TamCore Pacific -Yamaichi International (H.K.) Limited